课题基金 / 基金详情

项目摘要

项目成果

Kristian Graugaard Andersen的其他基金

相似基金

相关文献

中文摘要
翻译
先前的研究表明,在大流行之前,塞拉利昂人更频繁地 比美国人暴露于冠状病毒的表位与严重急性 呼吸道综合征冠状病毒2型(SARS-CoV-2)、SARS-CoV和中东呼吸道 综合征冠状病毒(MERS-CoV)。既往暴露于冠状病毒,可诱导交叉保护 免疫力可能有助于大幅降低塞拉利昂的COVID-19病例和死亡率 塞拉利昂与美国相比。这种补充将(1)定义体液免疫 塞拉利昂人的反应,可以防止感染SARS-CoV-2, 大流行前单克隆抗体分离和鉴定,(2)开发诊断 新型冠状病毒的测试和(3)确定交叉中和的保护性反应 在非人灵长类动物COVID-19模型中的单克隆抗体。
英文摘要
Prior studies have shown that prior to the pandemic, Sierra Leoneans had more frequent exposures than Americans to coronaviruses with epitopes that cross-react with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), SARS-CoV, and Middle Eastern respiratory syndrome coronavirus (MERS-CoV). Prior exposure to coronaviruses that induce cross-protective immunity may contribute to the greatly reduced incidence of COVID-19 cases and deaths in Sierra Leone compared to the United States. This supplement will (1) define the humoral immune response of Sierra Leoneans that may protect against infection with SARS-CoV-2 through isolation and characterization of pre-pandemic monoclonal antibodies, (2) develop diagnostic tests for novel coronaviruses and (3) determine the protective responses of cross neutralizing monoclonal antibodies in a nonhuman primate COVID-19 model.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
West African Emerging Infectious Disease Research Center (WA-EIDRC)
  • 批准号:
    10653441
  • 项目类别:
  • 资助金额:
    $184.89万
  • 财政年份:
    2022
  • 负责人:
    Kristian Graugaard Andersen
  • 依托单位:
Consortium for Viral Systems Biology (CViSB)
  • 批准号:
    10469781
  • 项目类别:
  • 资助金额:
    $59.71万
  • 财政年份:
    2021
  • 负责人:
    Kristian Graugaard Andersen
  • 依托单位:
Consortium for Viral Systems Biology Administrative Core
  • 批准号:
    10469782
  • 项目类别:
  • 资助金额:
    $59.71万
  • 财政年份:
    2021
  • 负责人:
    Kristian Graugaard Andersen
  • 依托单位:
West African Emerging Infectious Disease Research Center (WA-EIDRC)
  • 批准号:
    10440593
  • 项目类别:
  • 资助金额:
    $26.63万
  • 财政年份:
    2021
  • 负责人:
    Kristian Graugaard Andersen
  • 依托单位:
海外基金